dendrit
cell
express
lectin
receptor
like
dcsign
allow
cell
sens
glycan
present
variou
bacteri
viral
pathogen
interact
dcsign
carbohydr
moieti
induc
matur
dendrit
cell
promot
endocytosi
pathogen
import
properti
profession
antigen
present
cell
uptak
pathogen
dendrit
cell
may
lead
crosspresent
antigen
infect
cell
ultim
result
activ
virusspecif
cell
drain
lymph
node
littl
known
interact
dcsign
influenza
virus
show
viru
nonfunct
receptor
bind
site
hemagglutinin
replic
cell
express
dcsign
also
absenc
sialic
acid
receptor
influenza
virus
virus
replic
dcsign
express
cell
includ
human
dendrit
cell
furthermor
effici
dcsign
mediat
infect
depend
extent
glycosyl
viral
hemagglutinin
dcsign
dendrit
cellspecif
intercellular
adhes
nonintegrin
ctype
lectin
mainli
present
surfac
dendrit
cell
dc
dc
antigen
present
cell
play
key
role
induct
adapt
immun
respons
abl
present
antigen
cell
induc
matur
dcsign
signal
modul
statu
dc
trigger
matur
promot
adapt
immun
respons
dcsign
belong
collectin
famili
recogn
glycan
pathogen
exampl
ligand
dcsign
includ
bacteria
sever
virus
cytomegaloviru
dengu
viru
ebola
viru
hepat
c
viru
human
immunodefici
viru
sarscoronaviru
west
nile
viru
littl
known
interact
dcsign
influenza
virus
influenza
virus
belong
famili
orthomyxovirida
genom
consist
eight
neg
strand
rna
segment
encod
eleven
protein
two
protein
hemagglutinin
ha
neuraminidas
na
protrud
viral
envelop
recogn
sialic
acid
carbohydr
side
chain
cellular
glycoprotein
glycolipid
ha
bind
sialic
acid
via
receptor
bind
site
rb
form
pocket
highli
conserv
amino
acid
bind
receptor
viru
intern
via
endocytosi
low
ph
endosom
caus
ha
undergo
conform
chang
lead
exposur
fusion
peptid
fusion
viral
endosom
membran
rna
segment
viru
deliv
cytoplasm
transport
nucleu
replic
initi
new
virion
assembl
cell
membran
na
cleav
sialic
acid
cell
membran
allow
newli
synthes
virion
detach
cell
sialic
acid
critic
factor
tropism
viru
type
linkag
galactos
residu
determin
whether
recogn
specif
virus
wide
present
avian
gastrointestin
tract
link
sialic
acid
prefer
recogn
avian
influenza
virus
hand
link
sialic
acid
abund
human
upper
respiratori
tract
prefer
recogn
human
influenza
virus
howev
bind
influenza
virus
cell
may
restrict
recognit
sialic
acid
rb
ha
found
lectin
receptor
bind
influenza
virus
suggest
mean
viru
attach
subsequ
entri
could
involv
cellular
lectin
receptor
may
recogn
glycan
ha
allow
bind
viru
cell
intern
thu
extent
glycosyl
ha
like
import
recognit
viru
cellular
lectin
glycosyl
achiev
post
translat
modif
asparagin
residu
nxst
motif
x
amino
acid
except
prolin
number
type
posit
glycan
vari
viru
might
affect
recognit
influenza
virus
lectin
receptor
dcsign
howev
role
dcsign
bind
entri
influenza
virus
studi
limit
extent
limit
number
virus
investig
furthermor
although
correl
extent
glycosyl
viral
envelop
protein
bind
dcsign
suggest
solid
evid
larg
lack
addit
unclear
dcsign
mediat
entri
could
support
product
infect
introduc
two
mutat
rb
ha
creat
mutant
viru
abl
bind
sialic
acid
mutant
serv
prove
dcsign
could
recogn
ha
way
support
viru
replic
select
nine
virus
investig
whether
express
dcsign
cell
line
dc
could
support
replic
virus
absenc
sialic
acid
furthermor
genet
modifi
two
virus
insert
delet
glycosyl
site
head
ha
show
bind
effici
dcsign
ha
subsequ
infect
rate
determin
extent
glycosyl
head
ha
final
demonstr
human
dc
captur
influenza
viru
interact
dcsign
lead
infect
cell
madindarbi
canin
kidney
mdck
cell
cultur
eagl
minimum
essenti
medium
vero
cell
dulbecco
modifi
eagl
medium
mdck
vero
cell
stabli
transfect
plasmid
express
human
dcsign
kindli
provid
dr
v
kewal
ramani
mg
plasmid
nucleofect
mdck
vero
cell
use
amaxah
system
lonza
cologn
germani
next
day
cell
wash
cultur
presenc
mgml
mdck
vero
cell
express
dcsign
cell
isol
use
microbead
miltneyi
biotec
germani
follow
manufactur
instruct
dcsign
express
monitor
flowcytometri
incub
anti
antibodi
label
phycoerythrin
pe
two
passag
mdck
dcsign
vero
dcsign
cell
cultur
presenc
mgml
dcsign
express
check
passag
flow
cytometri
dcsign
transgen
mdck
vero
cell
gener
permiss
committe
genet
modif
cogem
permit
number
influenza
viru
defici
rb
gener
use
revers
genet
amino
acid
posit
target
sinc
crucial
receptor
bind
end
ha
gene
segment
influenza
viru
apuerto
modifi
site
direct
mutagenesi
quikchang
multi
sitedirect
mutagenesi
kit
stratagen
leusden
netherland
yield
ha
amino
acid
substitut
bidirect
revers
genet
plasmid
contain
wildtyp
wt
mutant
ha
cotransfect
cell
plasmid
encod
na
gene
segment
major
replac
gene
encod
green
fluoresc
protein
gfp
plasmid
encod
remain
six
gene
segment
influenza
viru
supernat
use
subsequ
inocul
mdck
mdckdc
sign
cell
presenc
neuraminidas
vibrio
cholera
sigmaaldrich
saint
loui
mo
uml
virus
design
respect
use
subsequ
inocul
mdck
mdck
dcsign
cell
passag
figur
five
virus
anetherland
four
virus
select
propag
mdck
cell
describ
previous
cultur
supernat
infect
mdck
cell
clarifi
low
speed
centrifug
aliquot
store
use
infecti
viru
titer
determin
describ
previous
mutant
virus
made
previous
describ
ha
gene
segment
two
virus
clone
bidirect
revers
genet
plasmid
sitedirect
mutagenesi
quikchang
multi
sitedirect
mutagenesi
kit
stratagen
leusden
netherland
nlink
glycosyl
site
reciproc
exchang
produc
virus
gain
lost
one
put
nlink
glycosyl
site
plasmid
encod
wildtyp
mutant
ha
gene
cotransfect
cell
plasmid
encod
remain
gene
segment
backbon
strain
describ
previous
use
mutant
lack
one
glycosyl
site
also
use
mutant
lack
one
glycosyl
site
mutant
contain
three
addit
glycosyl
site
present
anetherland
virus
passag
time
use
inocul
mdck
mdck
dcsign
cell
moi
titer
passag
low
viru
passag
use
determin
multistep
replic
kinet
cultur
supernat
collect
hour
inocul
infecti
viru
titer
determin
mdck
mdck
dcsign
cell
previous
describ
virus
passag
time
use
inocul
mdck
mdck
dcsign
cell
moi
gfp
express
infect
cell
analyz
flow
cytometri
hour
post
inocul
use
fac
calibur
cell
quest
pro
softwar
becton
dickinson
mdck
vero
cell
treat
uml
neuraminidas
vibrio
cholera
sigma
aldrich
zwijndrecht
netherland
golgistop
bd
bioscienc
san
diego
ca
minut
remov
sialic
acid
cell
surfac
golgistop
protein
transport
inhibitor
use
result
accumul
protein
golgi
complex
remov
sialic
acid
confirm
flow
cytometri
stain
biotinlabel
sambucu
nigra
sna
lectin
dilut
bind
link
sialic
acid
maackia
amurensi
maa
lectin
bind
link
sialic
acid
minut
subsequ
stain
streptavidin
label
fluorescein
isothiocyan
fitc
zebra
bioscienc
follow
manufactur
instruct
use
mixtur
lectin
sna
maa
sanbio
bv
uden
netherland
detect
sialic
acid
present
mdck
vero
cell
assay
perform
confirm
na
treatment
effect
confirm
absenc
sialosaccharid
present
mdck
cell
untreat
cell
use
posit
control
inocul
variou
virus
multipl
infect
tcid
per
cell
one
hour
presenc
uml
neuraminidas
vibrio
cholera
golgistop
bd
bioscienc
san
diego
ca
inoculum
aspir
cell
wash
incub
cultur
medium
hour
cell
transfer
vbottom
plate
wash
twice
pb
contain
fetal
bovin
serum
stain
viabil
use
amcyanlabel
livedead
stain
invitrogen
oregon
usa
wash
cell
fix
ml
cytofix
bd
bioscienc
san
diego
ca
accord
manufactur
recommend
subsequ
cell
wash
twice
cytoperm
bd
bioscienc
san
diego
ca
incub
monoclon
antibodi
specif
viral
nucleoprotein
label
fitc
dakocytom
glostrup
denmark
wash
twice
cell
analyz
flow
cytometri
use
diva
h
softwar
assay
describ
optim
valid
care
use
two
differ
virus
reproduc
assay
confirm
perform
assay
least
three
time
final
experi
larg
panel
virus
perform
duplic
confirm
entri
mediat
dcsign
vero
vero
dcsign
treat
neuraminidas
vibrio
cholera
minut
remov
sialic
acid
cell
surfac
incub
without
mg
antibodi
dcsign
result
shown
figur
viru
replic
mdck
mdck
dcsign
cell
hour
viru
titer
reach
inocul
mdck
mdck
dcsign
cell
passag
respect
contrast
viru
viru
could
rescu
mdck
cell
five
independ
attempt
infecti
viru
detect
two
subsequ
passag
cell
figur
howev
upon
passag
mdck
dcsign
cell
viru
could
readili
propag
although
titer
reach
lower
viru
hour
inocul
mdck
dcsign
cell
passag
respect
two
passag
mdck
dcsign
cell
replic
viru
mdck
cell
undetect
wherea
three
passag
viru
titer
reach
mdck
cell
hour
post
inocul
almost
lower
titer
reach
mdck
dcsign
cell
hour
post
inocul
virus
passag
use
inocul
mdck
mdck
dcsign
cell
moi
express
gfp
assess
flow
cytometri
figur
hour
data
shown
post
inocul
result
confirm
viru
function
ha
molecul
abl
infect
mdck
mdck
dcsign
cell
regardless
cell
line
use
produc
viru
figur
shown
figur
influenza
viru
obtain
two
three
passag
mdck
dcsign
cell
infect
larger
proport
mdck
dcsign
cell
mdck
cell
arrow
accord
differ
replic
kinet
observ
two
cell
line
order
remov
sialic
acid
normal
receptor
influenza
virus
mdck
vero
cell
treat
neuraminidas
vibrio
cholera
success
treatment
confirm
flow
cytometri
use
biotinlabel
lectin
maa
sna
figur
untreat
cell
use
posit
control
inocul
infect
percentag
cell
assess
first
compar
infect
rate
untreat
mdck
mdck
dcsign
cell
vero
vero
dcsign
cell
expect
infect
percentag
differ
significantli
cell
express
dcsign
figur
r
valu
vero
mdck
cell
respect
sinc
virus
display
differ
infect
rate
infect
rate
express
rel
posit
control
sialic
acid
nine
virus
test
abl
infect
mdck
mdck
dcsign
vero
vero
dcsign
cell
presenc
sialic
acid
remov
sialic
acid
mdck
vero
cell
infect
percentag
rel
untreat
posit
control
drop
consider
virus
mean
rel
number
infect
cell
vero
cell
mdck
cell
respect
figur
b
differ
observ
virus
may
explain
differ
number
nlink
glycosyl
site
present
ha
tabl
number
put
nlink
glycosyl
site
predict
onlin
softwar
nglycnet
correl
dcsign
mediat
infect
cell
howev
remain
unclear
extent
glycosyl
site
fact
util
confirm
entri
virus
mediat
via
dcsign
vero
vero
dcsign
cell
incub
dc
sign
block
antibodi
subsequ
infect
influenza
virus
shown
figur
e
f
infect
rate
reduc
presenc
antibodi
presenc
control
antibodi
isotyp
furthermor
also
presenc
mannos
entri
block
indic
dcsign
function
abl
bind
mannan
dc
three
differ
healthi
blood
donor
isol
treat
neuraminidas
vibrio
cholera
subsequ
inocul
virus
infect
rate
dc
obtain
differ
donor
vari
donor
display
infect
cell
infect
respect
donor
show
infect
cell
infect
respect
donor
display
infect
rate
respect
absenc
sialic
acid
infect
percentag
reduc
rang
untreat
dc
depend
viru
blood
donor
test
figur
howev
presenc
block
antidcsign
antibodi
percentag
decreas
significantli
mannwhitney
test
wherea
addit
control
present
studi
show
express
dcsign
facilit
infect
cell
influenza
virus
independ
sialic
acid
natur
receptor
virus
express
target
cell
first
gener
viru
mutat
receptor
bind
site
prove
imposs
rescu
viru
mdck
cell
howev
use
mdck
cell
constitut
express
dcsign
viru
readili
rescu
furthermor
determin
nucleotid
sequenc
passag
find
sign
revers
rb
wild
type
sequenc
although
emerg
minor
variant
bind
sialic
acid
exclud
interest
recent
demonstr
influenza
virus
enter
cho
cell
sialic
acid
independ
way
although
exact
mechan
remain
elus
altern
mdck
cell
may
support
replic
mutant
viru
anoth
unknown
ineffici
way
note
use
gener
rb
defici
viru
howev
absenc
sialic
acid
viru
replic
rel
poorli
dcsign
express
mdck
vero
cell
may
relat
rel
low
number
nlink
glycosyl
site
ha
may
reduc
window
opportun
measur
differ
infect
rate
cell
without
dcsign
next
explor
opposit
approach
remov
natur
receptor
influenza
virus
mdck
vero
cell
treatment
neuraminidas
assess
effect
dcsign
express
infect
ratesof
nine
differ
influenza
virus
subtyp
obtain
variou
speci
inde
virus
test
presenc
dcsign
mediat
viru
entri
infect
cell
explain
bind
dcsign
glycan
ha
virus
follow
endocytosi
viru
fusion
viral
envelop
endosom
membran
initi
step
viru
replic
cycl
interest
virus
display
effici
dcsign
mediat
infect
absenc
sialic
acid
rel
larg
number
put
nlink
glycosyl
site
ha
order
confirm
inde
interact
dcsign
glycan
ha
basi
observ
increas
infect
percentag
dcsign
express
cell
use
genet
modifi
influenza
virus
nlink
glycosyl
site
reciproc
exchang
produc
virus
gain
lost
one
put
nlink
glycosyl
site
gener
remov
nlink
glycosyl
site
reduc
dcsign
mediat
infect
mdck
vero
cell
wherea
addit
nlink
glycosyl
site
increas
infect
cell
figur
thu
dcsign
act
altern
receptor
influenza
virus
bind
glycan
present
ha
initi
viru
replic
cycl
although
suggest
extent
glycosyl
ha
determin
effici
recognit
dcsign
provid
first
time
solid
evid
inde
case
use
larg
panel
virus
isogen
virus
mutat
nlink
glycosyl
site
interest
also
suggest
virus
bind
dcsign
howev
littl
infect
dcsign
express
cell
observ
sialidas
treatment
cell
might
explain
poor
util
put
nlink
glycosyl
site
ha
viru
use
prevent
bind
dcsign
also
observ
investig
bind
virus
solubl
ctype
lectin
porcin
surfact
protein
final
test
dc
cell
interest
express
dcsign
vivo
addit
human
alveolar
macrophag
also
use
receptor
bind
influenza
virus
end
sialic
acid
remov
shown
infect
dc
could
inhibit
monoclon
antibodi
specif
dcsign
thu
dc
becom
infect
absenc
sialic
acid
bind
glycan
present
ha
influenza
viru
suggest
previous
viru
dc
cocultur
mdck
cell
like
nonspecif
bind
glycosyl
pathogen
univers
properti
dc
may
contribut
induct
adapt
immun
respons
pathogen
find
may
implic
heavili
glycosyl
influenza
virus
effici
infect
dc
subsequ
may
induc
stronger
immun
respons
virus
less
heavili
glycosyl
inde
extent
glycosyl
shown
invers
correl
virul
influenza
virus
attribut
increas
sensit
action
collectin
defenc
molecul
innat
immun
system
increas
suscept
infect
dc
may
blunt
infect
heavili
glycosyl
influenza
virus
collect
shown
dcsign
captur
influenza
virus
support
infect
cell
express
dcsign
effici
process
depend
extent
glycosyl
viral
ha
research
requir
relat
extent
dcsign
mediat
infect
dc
magnitud
immun
respons
infect
viru
specif
cell
respons
particular
